All Stories

  1. Statistical analysis plan for Love Your Brain: a multi-arm randomised controlled trial of a stroke prevention digital platform
  2. Enablers and barriers for scaling up non-communicable disease interventions across diverse global health contexts: a qualitative study using the Consolidated Framework for Implementation Research
  3. Sex Differences in Prescription, Initiation, and Discontinuation of Secondary Prevention Medications After Stroke
  4. Chronic Disease Management to Enhance Medication Adherence Trajectories in Long‐Term Survivors of Stroke: A Population‐Based Cohort Study
  5. Preventing Stroke Research Priorities Project: An Initiative of Synergies to Prevent Stroke (STOPstroke)
  6. Management of people after stroke in 383 Victorian general practices, 2014–2018: analysis of linked stroke registry and general practice data
  7. Strengthening policy engagement when scaling up interventions targeting non-communicable diseases: insights from a qualitative study across 20 countries
  8. Determining the Optimal Methodology for Identifying Incident Stroke Deaths Using Administrative Datasets Within Australia
  9. Incidence of thrombocytopenia-associated cerebral venous sinus thrombosis: a population-based study
  10. Statistical analysis plan for the Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke randomised controlled clinical trial
  11. Comparison of the performance of cardiovascular risk prediction tools in rural India: the Rishi Valley Prospective Cohort Study
  12. Pragmatic solutions to reduce the global burden of stroke: a World Stroke Organization–Lancet Neurology Commission
  13. Incidence of Stroke in the Aboriginal and Non-Aboriginal Populations of Australia: A Data Linkage Study
  14. Association Between Changes in Norepinephrine Infusion Rate and Urinary Oxygen Tension After Cardiac Surgery
  15. Large Burden of Stroke Incidence in People with Cardiac Disease: A Linked Data Cohort Study
  16. Antihypertensive Medication Adherence and the Risk of Vascular Events and Falls After Stroke: A Real-World Effectiveness Study Using Linked Registry Data
  17. Usability and acceptability of the software ‘Arogya Sahyog’ to assess non-communicable diseases in rural India
  18. A mixed-methods feasibility study of a new digital health support package for people after stroke: the Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke (ReCAPS) intervention
  19. Does a History of Cancer Influence the Effectiveness of Statins on Outcomes After Stroke?
  20. Global stroke statistics 2022
  21. Understanding of medications and associations with adherence, unmet needs, and perceived control of risk factors at two years post-stroke
  22. Mixed methods evaluation to explore participant experiences of a pilot randomized trial to facilitate self‐management of people living with stroke: Inspiring virtual enabled resources following vascular events (iVERVE)
  23. Personalized knowledge to reduce the risk of stroke (PERKS-International): Protocol for a randomized controlled trial
  24. Exploring dimensions of quality-of-life in survivors of stroke with communication disabilities – a brief report
  25. Costs of acute hospitalisation for stroke and transient ischaemic attack in Australia
  26. Absolute cardiovascular risk scores and medication use in rural India: a cross-sectional study
  27. The Allure of Big Data to Improve Stroke Outcomes: Review of Current Literature
  28. Exploring Barriers to and Enablers of the Adoption of Information and Communication Technology for the Care of Older Adults With Chronic Diseases: Scoping Review
  29. Case-Fatality and Functional Outcome after Subarachnoid Hemorrhage (SAH) in INternational STRoke oUtComes sTudy (INSTRUCT)
  30. Optimal Measures for Primary Care Physician Encounters after Stroke and Association with Survival: A Data Linkage Study
  31. Co-Designing a New Yoga-Based Mindfulness Intervention for Survivors of Stroke: A Formative Evaluation
  32. Treatment with Multiple Therapeutic Classes of Medication Is Associated with Survival after Stroke
  33. Greater Adherence to Secondary Prevention Medications Improves Survival After Stroke or Transient Ischemic Attack: A Linked Registry Study
  34. Quality of Care and One-Year Outcomes in Patients with Diabetes Hospitalised for Stroke or TIA: A Linked Registry Study
  35. Association of hypertension with infection and inflammation in a setting of disadvantage in rural India
  36. Utility of the Hospital Frailty Risk Score Derived From Administrative Data and the Association With Stroke Outcomes
  37. Intraoperative renal hypoxia and risk of cardiac surgery‐associated acute kidney injury
  38. Perspectives on rehabilitation for Aboriginal people with stroke: a qualitative study
  39. Protocol of a randomized controlled trial investigating the effectiveness of Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke (ReCAPS)
  40. The state of stroke services across the globe: Report of World Stroke Organization–World Health Organization surveys
  41. Exploring Barriers to and Enablers of the Adoption of Information and Communication Technology for the Care of Older Adults With Chronic Diseases: Scoping Review (Preprint)
  42. Fatal and non-fatal events within 14 days after early, intensive mobilization post stroke
  43. A longitudinal examination of the frequency and correlates of self-reported neurobehavioural disability following stroke
  44. Patterns of use and discontinuation of secondary prevention medications after stroke
  45. Sex differences in quality of life after stroke were explained by patient factors, not clinical care: evidence from the Australian Stroke Clinical Registry
  46. Hospital Presentations in Long-Term Survivors of Stroke
  47. Stroke incidence and subtypes in Aboriginal people in remote Australia: a healthcare network population-based study
  48. Hospital admissions prior to primary intracerebral haemorrhage and relevant factors associated with survival
  49. Assuming one dose per day yields a similar estimate of medication adherence in patients with stroke: An exploratory analysis using linked registry data
  50. Sex differences in aneurysmal subarachnoid haemorrhage (aSAH): aneurysm characteristics, neurological complications, and outcome
  51. Continuum of care approach for managing non-communicable diseases in low- and middle-income countries
  52. Hypertension in Rural India: The Contribution of Socioeconomic Position
  53. Incidence and risk factors for stroke following percutaneous coronary intervention
  54. Global Stroke Statistics 2019
  55. Factors Associated With 90-Day Readmission After Stroke or Transient Ischemic Attack
  56. Effectiveness of a scalable group-based education and monitoring program, delivered by health workers, to improve control of hypertension in rural India: A cluster randomised controlled trial
  57. Disparities in Antihypertensive Prescribing After Stroke
  58. Sex differences in risk factors for aneurysmal subarachnoid haemorrhage: Systematic review and meta-analysis
  59. Measuring stroke and transient ischemic attack burden in New Zealand: Protocol for the fifth Auckland Regional Community Stroke Study (ARCOS V)
  60. Blood Pressure, Aortic Stiffness, Hemodynamics, and Cognition in Twin Pairs Discordant for Type 2 Diabetes
  61. Sex Differences in Long-Term Quality of Life Among Survivors After Stroke in the INSTRUCT
  62. Protocol for evaluation of enhanced models of primary care in the management of stroke and other chronic disease (PRECISE)
  63. Early mobilization and quality of life after stroke
  64. Process evaluation in the field: global learnings from seven implementation research hypertension projects in low-and middle-income countries
  65. Prevalence of diabetes and pre-diabetes in rural Tehri Garhwal, India: influence of diagnostic method
  66. Factors that confound the prediction of renal medullary oxygenation and risk of acute kidney injury from measurement of bladder urine oxygen tension
  67. Multicenter, Prospective, Controlled, Before-and-After, Quality Improvement Study (Stroke123) of Acute Stroke Care
  68. Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  69. Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
  70. Promising Use of Big Data to Increase the Efficiency and Comprehensiveness of Stroke Outcomes Research
  71. Sex Differences in Care and Long-Term Mortality After Stroke: Australian Stroke Clinical Registry
  72. The role of context in implementation research for non-communicable diseases: Answering the ‘how-to’ dilemma
  73. Age, sex, and setting in the etiology of stroke study (ASSESS): Study design and protocol
  74. Evaluating recruitment strategies for AUSPICE , a large Australian community‐based randomised controlled trial
  75. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  76. Outcomes for Patients With In-Hospital Stroke: A Multicenter Study From the Australian Stroke Clinical Registry (AuSCR)
  77. Knowledge of risk factors for hypertension in a rural Indian population
  78. Stroke Severity Versus Dysphagia Screen as Driver for Post-stroke Pneumonia
  79. Sex Differences in Severity of Stroke in the INSTRUCT Study: a Meta‐Analysis of Individual Participant Data
  80. Large expert-curated database for benchmarking document
  81. A Promising Skills-Based Intervention to Reduce Blood Pressure in Individuals With Stroke and Transient Ischemic Attack
  82. Socioeconomic Status and Long-Term Stroke Mortality, Recurrence and Disability in Iran: The Mashhad Stroke Incidence Study
  83. Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016
  84. Maximising data value and avoiding data waste: a validation study in stroke research
  85. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
  86. Measuring progress of the health-related Sustainable Development Goals for 195 countries
  87. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
  88. Department of Error
  89. Task-shifting for cardiovascular risk factor management: lessons from the Global Alliance for Chronic Diseases
  90. Prevention of stroke: a global perspective
  91. Neurobehavioral disability in stroke patients during subacute inpatient rehabilitation: prevalence and biopsychosocial associations
  92. Understanding the potential for yoga and tai chi interventions to moderate risk factors for stroke – a scoping review
  93. Early Mobilization After Stroke Is Not Associated With Cognitive Outcome
  94. Long-term disability after stroke in Iran: Evidence from the Mashhad Stroke Incidence Study
  95. Factors influencing self-reported anxiety or depression following stroke or TIA using linked registry and hospital data
  96. Development of an electronic health message system to support recovery after stroke: Inspiring Virtual Enabled Resources following Vascular Events (iVERVE)
  97. Determining the feasibility and preliminary efficacy of a stroke instructional and educational DVD in a multinational context: a randomized controlled pilot study
  98. Excess stroke incidence in young Aboriginal people in South Australia: Pooled results from two population-based studies
  99. Evaluation of a training program of hypertension for accredited social health activists (ASHA) in rural India
  100. Advances in Stroke 2017
  101. Factors contributing to sex differences in functional outcomes and participation after stroke
  102. Five-Year Case Fatality Following First-Ever Stroke in the Mashhad Stroke Incidence Study: A Population-Based Study of Stroke in the Middle East
  103. Preventing stroke on the street where you live, work, and play
  104. Urinary hypoxia: an intraoperative marker of risk of cardiac surgery-associated acute kidney injury
  105. The Incidence and Characteristics of Stroke in Urban-Dwelling Iranian Women
  106. Quality of Life Is Poorer for Patients With Stroke Who Require an Interpreter
  107. Prescription of antihypertensive medication at discharge influences survival following stroke
  108. Five-Year Recurrence Rate and the Predictors Following Stroke in the Mashhad Stroke Incidence Study: A Population-Based Cohort Study of Stroke in the Middle East
  109. Self-Reported Exercise Prevalence and Determinants in the Long Term After Stroke: The North East Melbourne Stroke Incidence Study
  110. Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  111. Department of Error
  112. Improving quality and outcomes of stroke care in hospitals: Protocol and statistical analysis plan for the Stroke123 implementation study
  113. Global stroke statistics: An update of mortality data from countries using a broad code of “cerebrovascular diseases”
  114. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016
  115. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
  116. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  117. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  118. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
  119. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016
  120. Department of Error
  121. Community-Based Intervention to Improve Cardiometabolic Targets in Patients With Stroke
  122. Family-led rehabilitation after stroke in India (ATTEND): a randomised controlled trial
  123. Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015
  124. Long-term unmet needs and associated factors in stroke or TIA survivors
  125. Effectiveness of a shared team approach between nurses and doctors for improved risk factor management in survivors of stroke: a cluster randomized controlled trial
  126. Risk-adjusted hospital mortality rates for stroke: evidence from the Australian Stroke Clinical Registry (AuSCR)
  127. The potential health and economic impact of improving stroke care standards for Australia
  128. Developing consensus measures for global programs: lessons from the Global Alliance for Chronic Diseases Hypertension research program
  129. Effectiveness of an Intervention to Improve Risk Factor Knowledge in Patients With Stroke
  130. Innovative Approaches to Hypertension Control in Low- and Middle-Income Countries
  131. Sex Differences in Long-Term Mortality After Stroke in the INSTRUCT (INternational STRoke oUtComes sTudy)
  132. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015
  133. Factors associated with awareness, treatment and control of hypertension in a disadvantaged rural Indian population
  134. Incidence, recurrence, and long-term survival of ischemic stroke subtypes: A population-based study in the Middle East
  135. Global stroke epidemiology
  136. STROKOG (stroke and cognition consortium): An international consortium to examine the epidemiology, diagnosis, and treatment of neurocognitive disorders in relation to cerebrovascular disease
  137. Epidemiology of Intracranial and Extracranial Large Artery Stenosis in a Population-Based Study of Stroke in the Middle East
  138. Long-Term Outcomes of Ischemic Stroke of Undetermined Mechanism: A Population-Based Prospective Cohort
  139. Strategies to Improve Stroke Care Services in Low- and Middle-Income Countries: A Systematic Review
  140. Gaps in Hypertension Guidelines in Low- and Middle-Income Versus High-Income Countries
  141. Nurse-Led Intervention to Improve Knowledge of Medications in Survivors of Stroke or Transient Ischemic Attack: A Cluster Randomized Controlled Trial
  142. Neighborhood socioeconomic index and stroke incidence in a national cohort of blacks and whites
  143. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  144. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  145. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
  146. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
  147. Cluster randomised feasibility trial to improve the Control of Hypertension In Rural India (CHIRI): a study protocol
  148. Addressing the challenges of cross-jurisdictional data linkage between a national clinical quality registry and government-held health data
  149. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015
  150. Rationale and design of a randomized controlled trial of pneumococcal polysaccharide vaccine for prevention of cardiovascular events: The Australian Study for the Prevention through Immunization of Cardiovascular Events (AUSPICE)
  151. Maximizing Patient Recruitment and Retention in a Secondary Stroke Prevention Clinical Trial: Lessons Learned from the STAND FIRM Study
  152. The Global Alliance for Chronic Diseases Supports 15 Major Studies in Hypertension Prevention and Control in Low- and Middle-Income Countries
  153. Case-fatality and functional status three months after first-ever stroke in Vietnam
  154. Better outcomes for hospitalized patients with TIA when in stroke units
  155. The Global Burden of Anemia
  156. Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT)
  157. AVERT 2 (a very early rehabilitation trial, a very effective reproductive trigger): retrospective observational analysis of the number of babies born to trial staff
  158. Personalized medicine and stroke prevention: where are we?
  159. 10.1016/S0140-6736(15)60692-4
  160. Behaviour change strategies for reducing blood pressure-related disease burden: findings from a global implementation research programme
  161. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition
  162. Obesity Paradox versus Frailty Syndrome in First-Ever Ischemic Stroke Survivors
  163. A Risk Score to Predict Hypertension in Primary Care Settings in Rural India
  164. One-year case fatality rate following stroke in the Mashhad Stroke Incidence Study: a population-based study of stroke in Iran
  165. Authors’ Response to: Data sources for measuring the socioeconomic gradient of hypertension in rural populations of low- and middle-income countries
  166. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
  167. Exploring threats to generalisability in a large international rehabilitation trial (AVERT)
  168. Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial
  169. Longitudinal Relationships Between Cognitive Decline and Gait Slowing: The Tasmanian Study of Cognition and Gait
  170. New Strategy to Reduce the Global Burden of Stroke
  171. Statistical analysis plan (SAP) for Shared Team Approach between Nurses and Doctors For Improved Risk Factor Management (STANDFIRM): a randomised controlled trial
  172. Methodology of the Stroke Self-Management Rehabilitation Trial: An International, Multisite Pilot Trial
  173. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
  174. Update on the Global Burden of Ischemic and Hemorrhagic Stroke in 1990-2013: The GBD 2013 Study
  175. Atlas of the Global Burden of Stroke (1990-2013): The GBD 2013 Study
  176. Sex Differences in Stroke Incidence, Prevalence, Mortality and Disability-Adjusted Life Years: Results from the Global Burden of Disease Study 2013
  177. Statistical Analysis Plan (SAP) for a Very Early Rehabilitation Trial (AVERT): An International Trial to Determine the Efficacy and Safety of Commencing out of Bed Standing and Walking Training (Very Early Mobilization) within 24 h of Stroke Onset vs. ...
  178. The Stroke Riskometer™ App: Validation of a Data Collection Tool and Stroke Risk Predictor
  179. Trends Over Time in the Risk of Stroke After an Incident Transient Ischemic Attack
  180. Long-Term Costs of Stroke Using 10-Year Longitudinal Data From the North East Melbourne Stroke Incidence Study
  181. Progression of White Matter Hyperintensities of Presumed Vascular Origin Increases the Risk of Falls in Older People
  182. Rejoinder: Socioeconomic gradients and hypertension in low- and middle-income countries: a straw man and no solutions
  183. Expanding antiplatelet use for patients with stroke: The case for stroke of unknown type
  184. Geomagnetic Storms Can Trigger Stroke
  185. Do the socioeconomic and hypertension gradients in rural populations of low- and middle-income countries differ by geographical region? A systematic review and meta-analysis
  186. Adiposity has a greater impact on hypertension in lean than not-lean populations: a systematic review and meta-analysis
  187. Lower systolic blood pressure is associated with poorer survival in long-term survivors of stroke
  188. Advances in Stroke
  189. Discharge Is a Critical Time to Influence 10-Year Use of Secondary Prevention Therapies for Stroke
  190. Association between Farming and Chronic Energy Deficiency in Rural South India
  191. Estimating the annual number of strokes and the issue of imperfect data: an example from Australia
  192. Global stroke statistics
  193. Incidence of first ever stroke during Hajj ceremony
  194. Brain Structural Change and Gait Decline: A Longitudinal Population-Based Study
  195. What is Stroke Symptom Knowledge?
  196. Statin Therapy and Outcome After Ischemic Stroke
  197. The Prevalence, Impact and Economic Implications of Atrial Fibrillation in Stroke: What Progress Has Been Made?
  198. Risk Factor Management in Survivors of Stroke: A Double-Blind, Cluster-Randomized, Controlled Trial
  199. A plea for the use of systematic review methodology when writing guidelines and timely publication of guidelines
  200. Baseline Smoking Status and the Long-Term Risk of Death or Nonfatal Vascular Event in People with Stroke
  201. Comparison of Stroke Warning Sign Campaigns in Australia, England, and Canada
  202. Vascular cognitive impairment and Alzheimer’s disease: role of cerebral hypoperfusion and oxidative stress
  203. Is Stroke Incidence in Low- to Middle-Income Countries Driven by Economics?
  204. Organized Blood Pressure Control Programs to Prevent Stroke in Australia
  205. Urinary symptoms and natural history of urinary continence after first-ever stroke—a longitudinal population-based study
  206. Advances in Health Policy and Outcome 2010–2011
  207. No Evidence for an Epidemic of Stroke with the Ageing of the Population
  208. Excess Risk of Stroke in Australia's Aboriginal and Torres Strait Islander Populations
  209. Factors associated with quality of life in 7-year survivors of stroke
  210. Gender-specific effects of caste and salt on hypertension in poverty: a population-based study
  211. Very Early Mobilization After Stroke Fast-Tracks Return to Walking: Further Results From the Phase II AVERT Randomized Controlled Trial
  212. How generalisable is INTERSTROKE?
  213. Protocol and Pilot Data for Establishing the Australian Stroke Clinical Registry
  214. Missed opportunities to prevent stroke recurrence
  215. Sex differences in presentation, severity, and management of stroke in a population-based study
  216. Potential roles of high salt intake and maternal malnutrition in the development of hypertension in disadvantaged populations
  217. The health loss from ischemic stroke and intracerebral hemorrhage: evidence from the North East Melbourne Stroke Incidence Study (NEMESIS)
  218. Systematic Review of Observational Studies
  219. Design and Methods of Population Surveys
  220. Case-Control Studies: The Importance of Design and Conduct
  221. Excessive Incidence of Stroke in Iran
  222. Stroke
  223. Estimating the Long-Term Costs Of Ischemic and Hemorrhagic Stroke for Australia
  224. Very Early Mobilisation and Complications in the First 3 Months after Stroke: Further Results from Phase II of A Very Early Rehabilitation Trial (AVERT)
  225. Incidence of Stroke Subtypes in the North East Melbourne Stroke Incidence Study (NEMESIS): Differences between Men and Women
  226. Smoking Cessation at 5 Years after Stroke in the North East Melbourne Stroke Incidence Study
  227. Teaching Courses
  228. Handicap 5 Years after Stroke in the North East Melbourne Stroke Incidence Study
  229. Individuals with first-ever clinical presentation of a lacunar infarction syndrome: Is there an increased likelihood of developing mild cognitive impairment in the first 12 months after stroke?
  230. Benefits and Challenges in Stroke Research in Developing Countries
  231. Patterns of Stroke Recurrence According to Subtype of First Stroke Event: The North East Melbourne Stroke Incidence Study (NEMESIS)
  232. Not All Stroke Units Are the Same: A Comparison of Physical Activity Patterns in Melbourne, Australia, and Trondheim, Norway
  233. Editorial
  234. A Very Early Rehabilitation Trial for Stroke (AVERT): Phase II Safety and Feasibility
  235. Estimating the Prevalence of Sleep-Disordered Breathing in Community-Based, Long-Term Stroke Survivors Using a Validated Predictive Model
  236. The effect of very early mobilisation after stroke on psychological well-being
  237. Economic Evaluation alongside a Phase II, Multi-Centre, Randomised Controlled Trial of Very Early Rehabilitation after Stroke (AVERT)
  238. Chapter 17 Stroke among women, ethnic groups, young adults, and children
  239. Risk Factors for Dementia
  240. Poverty and Stroke in India
  241. Why invest in a national public health program for stroke?
  242. The Large and Growing Burden of Stroke
  243. Is prestroke use of angiotensin-converting enzyme inhibitors associated with better outcome?
  244. Aboriginal and Torres Strait Islander Peoples and the Burden of Stroke
  245. Mobilisation ‘in Bed’ Is Not Mobilisation
  246. Vascular Cognitive Impairment
  247. Prevalence of Depression and Use of Antidepressant Medication at 5-Years Poststroke in the North East Melbourne Stroke Incidence Study
  248. Long-Term Cognitive Transitions, Rates of Cognitive Change, and Predictors of Incident Dementia in a Population-Based First-Ever Stroke Cohort
  249. A Very Early Rehabilitation Trial (AVERT)
  250. Control of Hypertension 5 Years After Stroke in the North East Melbourne Stroke Incidence Study
  251. Greater Incidence of Both Fatal and Nonfatal Strokes in Disadvantaged Areas: The Northeast Melbourne Stroke Incidence Study
  252. The validity of brief screening cognitive instruments in the diagnosis of cognitive impairment and dementia after first-ever stroke
  253. Development and application of Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS): An Australian economic model for stroke
  254. Long-Term Outcome in the North East Melbourne Stroke Incidence Study
  255. HYPERTENSION 2020: CONFRONTING TOMORROW'S PROBLEM TODAY
  256. Cerebrovascular disease and dementia
  257. Knowledge of risk factors and warning signs of stroke
  258. Stroke Units, Tissue Plasminogen Activator, Aspirin and Neuroprotection: Which Stroke Intervention Could Provide the Greatest Community Benefit?
  259. Quality of Life After Stroke
  260. Progressive dementia after first-ever stroke: A community-based follow-up study
  261. Cholesterol Is Associated With Stroke, but Is Not a Risk Factor
  262. Trial Application of a Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS) to Assist Priority Setting in Stroke
  263. Determinants of Handicap After Stroke
  264. Inactive and Alone: Physical Activity Within the First 14 Days of Acute Stroke Unit Care
  265. ‘Out of pocket’ costs to stroke patients during the first year after stroke – results from the North East Melbourne Stroke Incidence Study
  266. Smoking as a Crucial Independent Determinant of Stroke
  267. Lifetime Cost of Stroke Subtypes in Australia
  268. Editorial Comment—Minor Risk Factors for Intracerebral Hemorrhage: The Jury Is Still Out
  269. Risk of Ischemic Stroke Among Users of the Oral Contraceptive Pill
  270. Increased Risk of Cognitive Impairment 3 Months After Mild to Moderate First-Ever Stroke
  271. The role of blood pressure lowering before and after stroke
  272. Incidence and Outcome of Subtypes of Ischaemic Stroke: Initial Results from the North East Melbourne Stroke Incidence Study (NEMESIS)
  273. Brief Comprehensive Quality of Life Assessment After Stroke
  274. RE: "DOES TEA AFFECT CARDIOVASCULAR DISEASE? A META-ANALYSIS"
  275. Reduced frequency of high cholesterol levels among patients with intracerebral haemorrhage
  276. Informal Care for Stroke Survivors
  277. Handicap After Stroke: How Does It Relate to Disability, Perception of Recovery, and Stroke Subtype?
  278. Reduced Risk of Intracerebral Hemorrhage With Dynamic Recreational Exercise but Not With Heavy Work Activity
  279. Incidence of the Major Stroke Subtypes
  280. Inter-rater reliability of stroke sub-type classification by neurologists and nurses within a community-based stroke incidence study
  281. Hypertension and the risk of intracerebral haemorrhage: special considerations in patients with renal disease
  282. Heavy Drinking, but Not Moderate or Intermediate Drinking, Increases the Risk of Intracerebral Hemorrhage
  283. Ischemic stroke risk and passive exposure to spouses' cigarette smoking. Melbourne Stroke Risk Factor Study (MERFS) Group.
  284. Interrater Reliability of the National Institutes of Health Stroke Scale: Rating by Neurologistsand N urses in a Community-Based Stroke Incidence Study
  285. The Risk of Intracerebral Haemorrhage with Smoking
  286. Acute Brain Infarction: Early Changes in Neurological Status
  287. Risk Factors for Cerebral Hemorrhage in the Era of Well-Controlled Hypertension
  288. Epidemiology of Intracerebral Hemorrhage
  289. Hypertension as a Risk Factor for Stroke Subtypes
  290. Smoking as a Risk Factor for Stroke